How should hyponatremia with a serum sodium of 122 mEq/L be managed?

Management of Hyponatremia with Serum Sodium 122 mEq/L

For a serum sodium of 122 mEq/L, your management hinges entirely on symptom severity and volume status: severely symptomatic patients require immediate hypertonic saline to raise sodium by 5–6 mEq/L within the first hour, while asymptomatic or mildly symptomatic patients should receive volume-status–directed therapy (isotonic saline for hypovolemia, fluid restriction for hypervolemia) with correction not exceeding 8 mEq/L per 24 hours. 1

Immediate Assessment: Symptom Severity

Severely Symptomatic (Medical Emergency)

• Look for: altered mental status, seizures, coma, obtundation, somnolence, or cardiorespiratory distress 2
• Action: Administer 3% hypertonic saline as a 100–150 mL bolus immediately 3, 2
• Target: Raise serum sodium by 5–6 mEq/L within the first 1–2 hours to reverse cerebral edema 3, 2
• Critical ceiling: Do not exceed 8 mEq/L total correction in any 24-hour period to prevent osmotic demyelination syndrome 3, 1, 2
• Transfer to ICU with Q2-hour sodium monitoring 3

Mildly Symptomatic or Asymptomatic

• Mild symptoms include: nausea, vomiting, headache, weakness, mild confusion 4, 2
• Do not use hypertonic saline in asymptomatic chronic hyponatremia, as it risks volume overload and offers no benefit 1
• Proceed to volume-status assessment below 1, 5

Volume Status Determination (Essential First Step)

Clinical Indicators to Assess

• Hypovolemia: Orthostatic hypotension, dry mucous membranes, decreased skin turgor, flat neck veins 5, 6
• Hypervolemia: Peripheral edema, ascites, elevated jugular venous pressure, pulmonary congestion, history of heart failure or cirrhosis 5, 6
• Euvolemia: Absence of both volume overload and depletion signs 5

Laboratory Confirmation

• Measure urine osmolality and urine sodium 5, 6
• Urine osmolality >100 mOsm/kg indicates inappropriate ADH activity (most common scenario) 5
• Plasma osmolality <275 mOsm/kg confirms true hypotonic hyponatremia 5

Treatment by Volume Status

Hypovolemic Hyponatremia

• Administer isotonic (0.9%) saline to expand plasma volume 1, 4
• Correct the underlying cause (e.g., diuretic cessation, gastrointestinal losses) 1
• In cirrhotic patients with diuretic-induced hyponatremia: Stop diuretics immediately and give isotonic saline; re-initiate diuretics cautiously only after sodium improves and renal function stabilizes 1

Euvolemic Hyponatremia (SIADH Most Common)

• Before diagnosing SIADH: Rule out hypothyroidism and adrenal insufficiency, as these mimic SIADH but require hormone replacement rather than fluid restriction 5
• Primary treatment: Fluid restriction to 1–1.5 L per day 3, 1
• Second-line options: Salt tablets or vaptans (tolvaptan, satavaptan) for short-term use (≤30 days only) 1
• Vaptans raise serum sodium in 45–82% of patients but carry risk of overly rapid correction 1

Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)

• Primary intervention: Fluid restriction to 1–1.5 L per day 1
• Stop diuretics if creatinine is rising or markedly elevated 1
• In cirrhotic patients: Consider albumin infusion (8 g per liter of ascites removed after large-volume paracentesis) to modestly raise sodium 1
• Do not use hypertonic saline, as it worsens volume overload and ascites 1

Correction Rate Guidelines

Standard Correction Targets

• Aim for 4–6 mEq/L per day in chronic or asymptomatic hyponatremia 1, 5
• Absolute ceiling: 8 mEq/L per 24 hours to prevent osmotic demyelination 3, 1, 2
• For severely symptomatic patients: Initial rapid rise of 5–6 mEq/L in the first hour is safe and necessary, then slow to stay within the 8 mEq/L/24-hour limit 3, 1

Calculating Sodium Deficit (for Hypertonic Saline)

• Formula: Sodium deficit (mEq) = Desired increase in Na (mEq/L) × (0.5 × ideal body weight in kg) 3
• 3% saline administration: Recalculate requirements after initial bolus; switch to asymptomatic protocol once severe symptoms resolve 3

Monitoring Frequency

• Severe symptoms or ICU patients: Q2-hour sodium checks 3
• Mild symptoms or intermediate care: Q4-hour sodium checks 3
• Asymptomatic patients: Daily sodium monitoring 3

Prevention of Osmotic Demyelination Syndrome

High-Risk Populations

• Advanced liver disease, chronic alcoholism, malnutrition, severe metabolic disturbances, liver transplant candidates 1
• In these patients: Consider limiting correction to 4–6 mEq/L per day (even more conservative than the 8 mEq/L ceiling) 1

If Overcorrection Occurs

• Re-lower serum sodium using electrolyte-free water or desmopressin 1
• Desmopressin can halt unwanted water diuresis and prevent inadvertent overcorrection 7, 8

Special Considerations for Neurosurgical Patients

Cerebral Salt Wasting (CSW) vs. SIADH

• CSW presents with hypovolemia and high urine sodium; requires invasive hemodynamic monitoring (central venous pressure) to distinguish from SIADH 3, 5
• Treatment divergence is critical: CSW requires volume replacement with isotonic saline plus fludrocortisone, whereas SIADH requires fluid restriction 3, 5
• For subarachnoid hemorrhage patients: Treat even at sodium 131–135 mEq/L to prevent vasospasm complications 3

Common Pitfalls to Avoid

• Do not restrict fluids in mild hyponatremia (sodium >125 mEq/L) unless the patient is hypervolemic, as restriction offers no benefit and may cause harm 1
• Do not use vaptans for longer than 30 days, as long-term satavaptan therapy increases all-cause mortality in advanced liver disease 1
• Do not diagnose SIADH without first excluding thyroid and adrenal disorders 5
• Do not use loop diuretics in dialysis patients unless residual urine output exceeds 100 mL/day 9
• Chronic hyponatremia should not be rapidly corrected, as treatment complications (osmotic demyelination) occur primarily in chronic cases 3

Emerging Evidence on Correction Rates

• A 2026 retrospective cohort of 13,988 patients found that faster sodium correction (>12 mEq/L per 24 hours) was associated with lower 90-day mortality compared to slow correction (<8 mEq/L), with no significant increase in osmotic demyelination 10
• A 2025 meta-analysis similarly showed rapid correction (≥8–10 mEq/L per 24 hours) reduced in-hospital mortality by 32 deaths per 1,000 patients compared to slow correction 11
• However, current guidelines still recommend the 8 mEq/L per 24-hour ceiling to minimize demyelination risk, particularly in high-risk populations 3, 1, 2

Drug-Induced Hyponatremia Considerations

• Review medications: Thiazide diuretics, SSRIs, carbamazepine, NSAIDs, and newer agents (SGLT2 inhibitors, immune checkpoint inhibitors) can all cause hyponatremia 12, 13
• Discontinue offending agents when identified, particularly diuretics in severe hyponatremia 1, 4